Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
CPRX on Nasdaq
Molly Harper - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
127K |
$285K |
$2.24 |
Feb 14, 2025 |
Direct |
Common Stock |
|
| Common Stock, par value $0.001 per share |
6.75K |
$15.1K |
$2.24 |
Feb 14, 2025 |
Direct |
|
|
| Options to purchase common stock |
134K |
|
|
Nov 27, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.